Amenamevir (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Amenamevir" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

2^nd place

8^th place

5^th place

22^nd place

4^th place

11^th place

3researchgate.net

120^th place

344^th place

222^nd place

312^th place

6,690^th place

low place

doi.org

dx.doi.org

Shoji, Naoko, Ayano (2020. december 2.). „Pharmaceuticals and Medical Device Agency approval summary: Amenamevir for the treatment of herpes zoster” (angol nyelven). The Journal of Dermatology 47 (7), 683–688. o. DOI:10.1111/1346-8138.15393. ISSN 1346-8138.
Yajima, Misako, Masaya (2017. március 1.). „Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor”. Antiviral Research 139, 95–101. o. DOI:10.1016/j.antiviral.2016.12.008. ISSN 1872-9096. PMID 28027917.
Kawashima, Makoto, Mariko (2017. november 1.). „Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study”. The Journal of Dermatology 44 (11), 1219–1227. o. DOI:10.1111/1346-8138.13948. ISSN 1346-8138. PMID 28681394.
Ueda, Yuhki, Soichiro (2020. április 1.). „Inhibitory effect of amenamevir on acute herpetic pain and postherpetic neuralgia in mice infected with herpes simplex virus-1”. Journal of Dermatological Science 98 (1), 50–57. o. DOI:10.1016/j.jdermsci.2020.03.004. ISSN 1873-569X. PMID 32284168.
Ohtsu, Yoshiaki, Kiyoshi (2018. december 1.). „Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents”. European Journal of Drug Metabolism and Pharmacokinetics 43 (6), 693–706. o. DOI:10.1007/s13318-018-0481-y. ISSN 2107-0180. PMID 29748821.
Kusawake, Tomohiro, Dorien (2017. november 1.). „Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults”. Advances in Therapy 34 (11), 2466–2480. o. DOI:10.1007/s12325-017-0634-4. ISSN 1865-8652. PMID 29076107.
Adeloye, Temitope, Adeep (2018. november 1.). „Amenamevir: Studies of Potential CYP3A-Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy Volunteers”. Clinical Pharmacology in Drug Development 7 (8), 844–859. o. DOI:10.1002/cpdd.586. ISSN 2160-7648. PMID 30044899.
Chono, Koji, Hiroshi (2013. február 1.). „Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus”. Antiviral Research 97 (2), 154–160. o. DOI:10.1016/j.antiviral.2012.12.006. ISSN 1872-9096. PMID 23261844.
Chono, Koji, Toru (2012. augusztus 15.). „Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir)”. Biochemical Pharmacology 84 (4), 459–467. o. DOI:10.1016/j.bcp.2012.05.020. ISSN 1873-2968. PMID 22687623.
Kusawake, Tomohiro, Donna (2017. december 1.). „Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies”. Advances in Therapy 34 (12), 2625–2637. o. DOI:10.1007/s12325-017-0642-4. ISSN 1865-8652. PMID 29134426.
Flick, Andrew C., Hong X. (2019. augusztus 22.). „Synthetic Approaches to the New Drugs Approved During 2017”. Journal of Medicinal Chemistry 62 (16), 7340–7382. o. DOI:10.1021/acs.jmedchem.9b00196. ISSN 1520-4804. PMID 30939001.

nih.gov

pubmed.ncbi.nlm.nih.gov

Yajima, Misako, Masaya (2017. március 1.). „Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor”. Antiviral Research 139, 95–101. o. DOI:10.1016/j.antiviral.2016.12.008. ISSN 1872-9096. PMID 28027917.
Kawashima, Makoto, Mariko (2017. november 1.). „Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study”. The Journal of Dermatology 44 (11), 1219–1227. o. DOI:10.1111/1346-8138.13948. ISSN 1346-8138. PMID 28681394.
Ueda, Yuhki, Soichiro (2020. április 1.). „Inhibitory effect of amenamevir on acute herpetic pain and postherpetic neuralgia in mice infected with herpes simplex virus-1”. Journal of Dermatological Science 98 (1), 50–57. o. DOI:10.1016/j.jdermsci.2020.03.004. ISSN 1873-569X. PMID 32284168.
Ohtsu, Yoshiaki, Kiyoshi (2018. december 1.). „Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents”. European Journal of Drug Metabolism and Pharmacokinetics 43 (6), 693–706. o. DOI:10.1007/s13318-018-0481-y. ISSN 2107-0180. PMID 29748821.
Kusawake, Tomohiro, Dorien (2017. november 1.). „Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults”. Advances in Therapy 34 (11), 2466–2480. o. DOI:10.1007/s12325-017-0634-4. ISSN 1865-8652. PMID 29076107.
Adeloye, Temitope, Adeep (2018. november 1.). „Amenamevir: Studies of Potential CYP3A-Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy Volunteers”. Clinical Pharmacology in Drug Development 7 (8), 844–859. o. DOI:10.1002/cpdd.586. ISSN 2160-7648. PMID 30044899.
Chono, Koji, Hiroshi (2013. február 1.). „Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus”. Antiviral Research 97 (2), 154–160. o. DOI:10.1016/j.antiviral.2012.12.006. ISSN 1872-9096. PMID 23261844.
Chono, Koji, Toru (2012. augusztus 15.). „Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir)”. Biochemical Pharmacology 84 (4), 459–467. o. DOI:10.1016/j.bcp.2012.05.020. ISSN 1873-2968. PMID 22687623.
Kusawake, Tomohiro, Donna (2017. december 1.). „Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies”. Advances in Therapy 34 (12), 2625–2637. o. DOI:10.1007/s12325-017-0642-4. ISSN 1865-8652. PMID 29134426.
Flick, Andrew C., Hong X. (2019. augusztus 22.). „Synthetic Approaches to the New Drugs Approved During 2017”. Journal of Medicinal Chemistry 62 (16), 7340–7382. o. DOI:10.1021/acs.jmedchem.9b00196. ISSN 1520-4804. PMID 30939001.

pmda.go.jp

Report on the Deliberation Results of Amenamevir

researchgate.net

wiley.com

onlinelibrary.wiley.com

Shoji, Naoko, Ayano (2020. december 2.). „Pharmaceuticals and Medical Device Agency approval summary: Amenamevir for the treatment of herpes zoster” (angol nyelven). The Journal of Dermatology 47 (7), 683–688. o. DOI:10.1111/1346-8138.15393. ISSN 1346-8138.

worldcat.org

Shoji, Naoko, Ayano (2020. december 2.). „Pharmaceuticals and Medical Device Agency approval summary: Amenamevir for the treatment of herpes zoster” (angol nyelven). The Journal of Dermatology 47 (7), 683–688. o. DOI:10.1111/1346-8138.15393. ISSN 1346-8138.
Yajima, Misako, Masaya (2017. március 1.). „Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor”. Antiviral Research 139, 95–101. o. DOI:10.1016/j.antiviral.2016.12.008. ISSN 1872-9096. PMID 28027917.
Kawashima, Makoto, Mariko (2017. november 1.). „Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study”. The Journal of Dermatology 44 (11), 1219–1227. o. DOI:10.1111/1346-8138.13948. ISSN 1346-8138. PMID 28681394.
Ueda, Yuhki, Soichiro (2020. április 1.). „Inhibitory effect of amenamevir on acute herpetic pain and postherpetic neuralgia in mice infected with herpes simplex virus-1”. Journal of Dermatological Science 98 (1), 50–57. o. DOI:10.1016/j.jdermsci.2020.03.004. ISSN 1873-569X. PMID 32284168.
Ohtsu, Yoshiaki, Kiyoshi (2018. december 1.). „Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents”. European Journal of Drug Metabolism and Pharmacokinetics 43 (6), 693–706. o. DOI:10.1007/s13318-018-0481-y. ISSN 2107-0180. PMID 29748821.
Kusawake, Tomohiro, Dorien (2017. november 1.). „Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults”. Advances in Therapy 34 (11), 2466–2480. o. DOI:10.1007/s12325-017-0634-4. ISSN 1865-8652. PMID 29076107.
Adeloye, Temitope, Adeep (2018. november 1.). „Amenamevir: Studies of Potential CYP3A-Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy Volunteers”. Clinical Pharmacology in Drug Development 7 (8), 844–859. o. DOI:10.1002/cpdd.586. ISSN 2160-7648. PMID 30044899.
Chono, Koji, Hiroshi (2013. február 1.). „Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus”. Antiviral Research 97 (2), 154–160. o. DOI:10.1016/j.antiviral.2012.12.006. ISSN 1872-9096. PMID 23261844.
Chono, Koji, Toru (2012. augusztus 15.). „Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir)”. Biochemical Pharmacology 84 (4), 459–467. o. DOI:10.1016/j.bcp.2012.05.020. ISSN 1873-2968. PMID 22687623.
Kusawake, Tomohiro, Donna (2017. december 1.). „Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies”. Advances in Therapy 34 (12), 2625–2637. o. DOI:10.1007/s12325-017-0642-4. ISSN 1865-8652. PMID 29134426.
Flick, Andrew C., Hong X. (2019. augusztus 22.). „Synthetic Approaches to the New Drugs Approved During 2017”. Journal of Medicinal Chemistry 62 (16), 7340–7382. o. DOI:10.1021/acs.jmedchem.9b00196. ISSN 1520-4804. PMID 30939001.